Aug 13, 2026 07:00AM
Jun 30, 2026 07:30AM
Jun 30, 2026 07:30AM
May 14, 2026 07:00AM
May 13, 2026 07:30AM
May 7, 2026 04:05PM
Apr 17, 2026 04:05PM Pyxis Oncology to present preclinical data on MICVO at AACR 2026
Apr 17, 2026 04:05PM
Mar 23, 2026 07:00AM
Mar 23, 2026 07:00AM
Feb 3, 2026 06:45AM
Feb 3, 2026 06:45AM
Jan 12, 2026 10:14AM
Dec 18, 2025 07:00AM Pyxis Oncology reports positive phase 1 data for cancer drug candidate
Dec 18, 2025 07:00AM
Nov 3, 2025 07:00AM
Oct 13, 2025 04:05PM
Apr 25, 2025 01:18PM
Apr 25, 2025 01:17PM
Mar 25, 2025 04:30PM
Mar 18, 2025 07:30AM Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Feb 26, 2025 07:31AM
Feb 26, 2025 07:30AM
Nov 28, 2023 07:11AM
Nov 28, 2023 07:00AM
May 24, 2023 06:45AM
May 24, 2023 06:45AM
May 11, 2023 07:00AM Pyxis Oncology Reports Financial Results for the First Quarter 2023 and Provides Corporate Update
Mar 22, 2023 06:45AM
Dec 1, 2022 07:39AM
Dec 1, 2022 06:45AM
Nov 1, 2022 06:30AM
Aug 15, 2022 07:00AM
Mar 29, 2022 11:01AM
Mar 29, 2022 11:00AM Biosion licenses BSI-060T (anti-Siglec-15) to Pyxis Oncology
Feb 7, 2022 07:55AM
Feb 7, 2022 07:55AM
Nov 2, 2021 07:38AM

329,624 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All